Effect of Foot Muscle Energy Technique in Patients With Diabetic Neuropathy

Effect of Foot Muscle Energy Technique in Patients With Diabetic Neuropathy: A Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05790421

Enrollment

Registered

2023-03-30

Start date

2022-04-02

Completion date

2023-01-03

Last updated

2023-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Neuropathies

Keywords

Diabetic neuropathy, Foot muscle energy technique, Isometric muscle strength, Motor nerve conduction velocity study

Brief summary

Foot muscle energy technique and conventional physical therapy program administered in patients with type 2 Diabetic Neuropathy.

Detailed description

Foot muscle energy technique and conventional physical therapy program administered in patients with type 2 Diabetic Neuropathy.

Interventions

OTHERFoot Muscle Energy Technique

Starting from the preparation position, at the restriction barrier, the patient is asked to exert a small effort (no more than 20% of available strength) towards plantarflexion, against unyielding resistance, with appropriate breathing. The patient produces isometric effort contracts either gastrocnemius or soleus (depending on whether the knee is unflexed or flexed). This contraction is held for 7-10 seconds together with a held breath. The exercise was repeated until the full range of movement was obtained.

OTHERConventional Physical Therapy Program

Graduated active resisted range of motion exercises for both UL and LL and graduated gait training

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

40 Years to 55 Years

Healthy volunteers

Inclusion criteria

* Participants (males and females) examined with non-insulin-dependent diabetes for ≥10 years determined by neurophysiological measurements were enrolled. * The participants regularly took their diabetes medications during the assessment and treatment period. * The use of any sedatives or anticonvulsants was contraindicated for all participants.

Exclusion criteria

• Uncontrolled non-insulin dependent diabetes and diagnosed for \< 10 years, neural, muscular, and skeletal system deformities; radiculopathy; and psychiatric disorders.

Design outcomes

Primary

Measure	Time frame	Description
Motor nerve conduction study	4 weeks	Assess both tibial and deep peroneal motor nerve conduction velocity.
Toe Strength Dynamometer	4 weeks	Assess Isometric muscle strength.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026